Permanent Discontinuation of Tyrosine Kinase Inhibitor Frontline Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Patients during the First 36 Months of Treatment: A "Campus CML" Study
Mulas, O;Caocci, G;Specchia, G;
2022-01-01
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.